Figure 3.
Changes in visual acuity (a) and central retinal thickness (b) following IVB therapy. CMT, central macular thickness; LogMAR, logarithm of minimal angel resolution; IVB, intravitreal bevacizumab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.